Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial. | Value Health;17(7): A372-3, 2014 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial.

Zhang, F; Tencer, T; Li, S; Strand, V.

Affiliation

Zhang F; Celgene Corporation, Warren, NJ, USA.
Tencer T; Celgene Corporation, Warren, NJ, USA.
Li S; Celgene Corporation, Warren, NJ, USA.
Strand V; Biopharmaceutical Consultant, Portola Valley, CA, USA.

Value Health ; 17(7): A372-3, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27200801

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Estados Unidos